LifeEDIT Therapeutics is Other Healthcare Technology Systems in United States that focus on base editors business. Founded in 2017. They cover business area such as operator, genome engineering, human disease, novel rgn, base editor, non-pathogenic organism, flexible editing, access, genomic locus, interest, genomic sequence, therapy, genetic disorder, genetic mutation.
Other Healthcare Technology Systems
2017
( 7 years old in 2024 )
Base Editors
-
104 T.W. Alexander Drive
Building 20, Research Triangle Park
Durham, NC 27709
United States
Private
operatorgenome engineeringhuman diseasenovel rgnbase editornon-pathogenic organismflexible editingaccessgenomic locusinterestgenomic sequencetherapygenetic disordergenetic mutation
* We use standard office opening hours in near LifeEDIT Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
LifeEDIT Therapeutics is Other Healthcare Technology Systems business from United States that founded in 2017 (7 years old in 2024), LifeEDIT Therapeutics business is focusing on Base Editors.
LifeEDIT Therapeutics headquarter office and corporate office address is located in 104 T.W. Alexander Drive Building 20, Research Triangle Park Durham, NC 27709 United States.
LifeEDIT Therapeutics was founded in United States.
In 2024, LifeEDIT Therapeutics is currently focus on base editors sector.
Above is snippet of Google Trends for "base editors" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with LifeEDIT Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
